Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability

BACKGROUND: Clinical trial transparency is important to participants, trialists, publishers, and regulators, and there have been recent major policy changes by the pharmaceutical industry regarding clinical study data sharing. However, it is unknown if these changes are enabling independent research...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopkins, Ashley M., Rowland, Andrew, Sorich, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161442/
https://www.ncbi.nlm.nih.gov/pubmed/30261889
http://dx.doi.org/10.1186/s12916-018-1154-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161442/
https://www.ncbi.nlm.nih.gov/pubmed/30261889
http://dx.doi.org/10.1186/s12916-018-1154-z

Ejemplares similares